Aim: This study was performed to evaluate the effect of systemic tylosin on mastitis rates, cull rates because of mastitis, and quality and quantity of milk production in dairy cows affected with subclinical mastitis.

Materials and Methods: A total of 130 California mastitis test (CMT)-positive cows were randomly selected and divided into four different treatment groups. All treatments were performed on the day of drying off. Cows in Group 1 (n=34) received 12 g of tylosin intramuscularly (IM) and intramammary (IMM) 400 mg novobiocin sodium and 200,000IU penicillin G procaine. Group 2 (n=33) received 12 g tylosin IM and IMM 280 mg benethamine penicillin, 100 mg penethamate hydriodide, and 100 mg framycetin sulfate. Group 3 (n=33) received IMM alone with 400 mg novobiocin sodium and 200,000 IU penicillin G procaine. Group 4 (n=30) received IMM alone with 280 mg benethamine penicillin, 100 mg penethamate hydriodide, and 100 mg framycetin sulfate. The incidence and severity of clinical mastitis (CM), incidence of chronic mastitis, and cow cull rate because of mastitis were recorded during the first 100 days in milk (DIM). In addition, somatic cell count (SCC) and milk production parameters including the average days to peak milk yield, the average milk yield at peak, the average milk yield during the first 100 DIM, and the average 305-corrected milk yield were reported.

Results: The rate of CM was significantly (p≤0.05) less in Group 2 when compared between the current and previous lactations (30% vs. 64%). In Group 1 and 4, the rate of CM was decreased but not significant between the two lactations (59% vs. 79% and 63% vs. 77%, respectively) while in Group 3, the rate of CM was slightly increased (82% vs. 91%). When compared between the four groups in the current lactation, CM rate was significantly (p≤0.05) less in Group 2 compared to the other groups. A significant (p≤0.05) percentage of CM cases in Group 2 was classified as mild. In Groups 1 and 3, a significant (p≤0.05) percentage of CM cases was classified as moderate while severe clinical signs were recorded more significantly (p≤0.05) in Groups 3 and 4. The rate of chronic mastitis was significantly less in Group 1 and Group 2 in the current lactation compared to that in the previous lactation (6% vs. 12% and 0% vs. 6%, respectively). In Groups 3 and 4, the rate of chronic mastitis was not changed significantly when compared between the current and previous lactations. No cows were culled because of mastitis in Groups 1 and 3 while one cow was culled in each of Groups 2 and 4 during the first 100 DIM in the current lactation. The average milk yield during the first 100 DIM and the 305-corrected milk yield were significantly (p≤0.05) increased in Group 2 when compared between the previous and current lactations. Furthermore, cows in Group 2 produced significantly (p≤0.05) more milk during the first 100 DIM and significantly (p≤0.05) more 305-corrected milk yield compared to the other groups. In Group 2, the average SCC dropped significantly (p≤0.05) from 1,600,000 cells/ml at the start of the study to <200,000 cells/ml at 100 DIM.

Conclusion: In dairy herds with subclinical mastitis, dry cow therapy of CMT-positive cows using a combination of tylosin (12 g, IM) and IMM administration of benethamine penicillin, penethamate hydriodide, and framycetin sulfate (Ubrostar; Boehringer Ingelheim, Germany) may result in a significant reduction of the rate and severity of acute and chronic mastitis and cull rates due to mastitis within the first 100 DIM. Furthermore, treated cows may produce significantly more milk with less SCC during the first 100 DIM and therefore produce significantly more 305-corrected milk in the lactation following treatment.

Keywords: dairy cows, dry cow therapy, subclinical mastitis, tylosin.

1. Berry, E.A. and Hillerton, J.E. (2002) The effect of selective dry cow treatment on new intramammary infections. J. Dairy Sci., 85(1): 112-121. [Crossref]

2. Bradley, A.J. and Green, M.J. (2004) The importance of the nonlactating period in the epidemiology of intramammary infection and strategies for prevention. Vet. Clin. Food Anim., 20(3): 547-568. [Crossref] [PubMed]

3. Bonnier, M., Dore, C., Amedeo, J. and Guerin-Faublee, V. (2006) In vitro activity of tylosin and tilmicosin against cocci isolated from bovine mastitis. Rev. Med. Vet., 157(10): 486-489.

4. Robert, A., Seegers, H. and Bareille, N. (2006) Incidence of intramammary infections during the dry period without or with antibiotic treatment in dairy cows-a quantitative analysis of published data. Vet. Res., 37(1): 25-48. [Crossref] [PubMed]

5. Pyorala, S. (2008) Mastitis in post-partum dairy cows. Reprod. Dom. Anim., 43(supplement 2): 252-259. [Crossref] [PubMed]

6. Simjee, S., Amedeo, J. and Barletta, A.M. (2011) Use of Tylan 200^® for the treatment of mastitis caused by Staphylococcus aureus and/or Streptococcus uberis. In: Hogeveen H., Lam T.J.G., editors. Udder Health and Communication. Wageningen Academic Publishers, Wageningen, The Netherlands. p295-295. [Crossref]

7. Rajala-Schultz, P.J., Torres, A.H. and DeGraves, F.J. (2011) Milk yield and somatic cell count during the following lactation after selective treatment of cows at dry-off. J. Dairy Res., 78(4): 489-499. [Crossref] [PubMed]

8. McDougall, S., Agnew, K.E., Cursons, R., Hou, X.X. and Compton, C.R.W. (2007) Parenteral treatment of clinical mastitis with tylosin base or penethamate hydriodide in dairy cattle. J. Dairy Sci., 90(2): 779-789. [Crossref]

9. Contreras, B.G.A., Guterbock, W.M., Mu-oz, R.J.M. and Sears, P.M. (2013) Comparison of systemic and intramammary dry cow treatments. Rev. MVZ Cordoba, 18(1): 3259-3264. [Crossref]

10. Halasa, T., Osteras, O., Hogeveen, H., van Weryn, T. and Nielen, M. (2009) Meta-analysis of dry cow management for dairy cattle. Part 1. Protection against new intramammary infections. J. Dairy Sci., 92(7): 3134-3149. [Crossref] [PubMed]

11. Alekish, M.O. (2015) The association between the somatic cell count and isolated microorganisms during subclinical mastitis in heifers in Jordan. Vet. Med. (Praha), 60(2): 71-76. [Crossref]

12. Al-Tarazi, Y.H., Chakiso, A.Y. and Lafi, S.Q. (2011) Prevalence and distribution of bovine mastitis pathogens and their antimicrobial resistance in primiparous dairy heifers in Northern Jordan. Jordan J. Agric. Sci., 7(3): 529-539.

13. Alekish, M.O., Al-Qudah, K. and Al-Saleh, A. (2013) Prevalence of antimicrobial resistance among bacterial pathogens isolated from bovine mastitis in northern Jordan. Rev. Med. Vet., 164(6): 319-326.

14. Ismail, Z.B. (2017) Molecular characteristics, antibiogram and prevalence of multi-drug resistant Staphylococcus aureus (MDRSA) isolated from milk obtained from culled dairy cows and from cows with acute clinical mastitis. Asian Pac. J. Trop. Biomed., 7(8): 694-697. [Crossref]

15. Huijps, K., Lam, T.J.G. and Hogeveen, H. (2008) Costs of mastitis: Facts and perception. J. Dairy Res., 75(1): 113-120. [Crossref] [PubMed]

16. Unnerstad, H.E., Lindberg, A., Waller, K.P., Ekman, T., Artursson, K., Nilsson-Ost, M. and Bengtsson B. (2009) Microbial etiology of acute clinical mastitis and agent-specific risk factors. Vet. Microbiol., 137(1-2): 90-97. [Crossref] [PubMed]

17. Persson, Y., Nyman, A.K. and Gronlund-Andersson, U. (2011) Etiology and antimicrobial susceptibility of udder pathogens from cases of subclinical mastitis in dairy cows in Sweden. Acta Vet. Scand., 53(1): 36. [Crossref] [PubMed] [PMC]

18. Awale, M.M., Dudhatra, G.B., Avinash, K., Chauhan, B.B., Kamani, D.R., Modi, C.M., Patel, H.B. and Mody, S.K. (2012) Bovine mastitis: A threat to economy. Open Access Sci. Rep., 1: 295.

19. De Vliegher, S., Fox, L.K., Piepers, S., McDougall, S. and Barkema, H.W. (2012) Invited review: Mastitis in dairy heifers: Nature of the disease, potential impact, prevention, and control. J. Dairy Sci., 95(3): 1025-1040. [Crossref] [PubMed]

20. Borm, A.A., Fox, L.K., Leslie, K.E., Hogan, J.S., Andrew, S.M., Moyes, K.M., Oliver, S.P., Schukken, Y.H., Hancock, D.D., Gaskins, C.T., Owens, W.E. and Norman, C. (2006) Effects of prepartum intramammary antibiotic therapy on udder health, milk production, and reproductive performance in dairy heifers. J. Dairy Sci., 89(6): 2090-2098. [Crossref]

21. Hagnestam, C., Emanuelson, U. and Berglund, B. (2007) Yield losses associated with clinical mastitis occurring in different weeks of lactation. J. Dairy Sci., 90(5): 2260-2270. [Crossref] [PubMed]

22. Sampimon, O.C., De Vliegher, S., Barkema, H.W., Sol, J. and Lam, T.J. (2009) Effect of prepartum dry cow antibiotic treatment in dairy heifers on udder health and milk production. J. Dairy Sci., 92(9): 4395-403. [Crossref] [PubMed]

---